Public lecture during Uppsala Health Summit
During next week’s Uppsala Health Summit on antibiotic resistance, Dr. Manica Balasegaram from the international Médecins Sans Frontières (MSF) will give a public lecture addressing this topic on June 1. Journalists also have the opportunity to attend the conference plenary sessions on June 2-3.
NOTE! Registration is required from media wishing to attend the conference.
The June 1 lecture is open to the general public.
Following last week’s decision to adopt the WHO Global Action Plan on Antimicrobial Resistance, the international Uppsala Health Summit meeting, to be held on June 2-3, symbolises the important next step: to convert the plan into concrete measures. Participants include representatives from a broad spectrum of influential international players. Due to a US initiative of President Barack Obama, some last-minute programme changes have been made. Dr. Ramanan Laxminarayan will now give his presentation via a video-link directly from Washington, for example.
In conjunction with the summit, Dr. Manica Balasegaram of the international MSF will hold a public lecture in the main Uppsala University building where he will talk about the problems and challenges that MSF encounters in its work. Dr. Balasegaram is president of the MSF Access Campaign, which started in 1999 to promote access to basic medicines, diagnostics and vaccines in resource-poor environments.
Facts
Press registration for Uppsala Health Summit:
anneli.waara@uadm.uu.se or 070-425 07 18.
Uppsala Health Summit is an international forum where invited decision makers, experts and opinion leaders in open dialogue seek ways to stimulate new research and innovation in order to improve care and health in the world.
Links
Information about the time and place for Dr Balasegaram’s public lecture:
http://www.kalendarium.uu.se/ViewPage.action?siteNodeId=12952&languageId=3&contentId=-1&eventId=12492
More information about Uppsala Health Summit, the programme and speakers
Read more about the current antibiotic resistance situation in the journal The Lancet